SAKAR HEALTHCARE Q2 FY27 ; CONS NET PROFIT UP 149% AT ₹11 CR (YOY), UP 10% (QOQ)

REVENUE UP 52% AT ₹87 CR (YOY), UP 20% (QOQ) EBITDA UP 114% AT ₹24 CR (YOY), UP 15% (QOQ) MARGINS AT 27.8% VS 19.7% (YOY), 29.1% (QOQ)

SAKAR HEALTHCARE LIMITED